ScienceDaily (2008-07-28) — An international team of scientists has identified processes that are heavily implicated in human multiple myeloma and other B cell cancers, moving us closer to developing quick tests and readouts that could help in the tailored treatment of patients.
“We already know that the over-expression or mutation of molecules known as NIK and TRAF3 in B cells is associated with human multiple myeloma,” said Professor Mackay. “Our collaborative research uncovered two distinct processes involving these molecules that help explain why.”
http://www.sciencedaily.com/releases/2008/07/080729133616.htm
Hi friend…. I am from Chennai, India.. and presently doing my Post Graduate in Biochemistry. At present i am doing my short project on MM. As it is rare in India…, i wont get any case to study… however, a few case i got… Still i wanted to know elaporately if you have any specific (i have your diagnosd report too…!!!) case pls do inform and the link from where i get..
Thanking you.
P Anand Raj.
Hey, I am glad to see I am not the only one to read Science Daily. ;-) But I haven’t read it in the past week or so, so I missed this article. Interesting! Thanks for posting about it.
Margaret
Florence, Italy